Edwards Lifesciences Corporation Company Profile (NYSE:EW)

About Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences Corporation logoEdwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:EW
  • CUSIP: 28176E10
  • Web: www.edwards.com
Capitalization:
  • Market Cap: $25.05465 billion
  • Outstanding Shares: 209,802,000
Average Prices:
  • 50 Day Moving Avg: $117.42
  • 200 Day Moving Avg: $103.28
  • 52 Week Range: $81.12 - $121.75
P/E:
  • Trailing P/E Ratio: 39.23
  • Foreward P/E Ratio: 29.73
  • P/E Growth: 2.22
Sales & Book Value:
  • Annual Revenue: $3.15 billion
  • Price / Sales: 7.86
  • Book Value: $13.04 per share
  • Price / Book: 9.05
Profitability:
  • EBIDTA: $1.01 billion
  • Net Margins: 20.85%
  • Return on Equity: 25.80%
  • Return on Assets: 15.36%
Debt:
  • Debt-to-Equity Ratio: 0.31%
  • Current Ratio: 3.45%
  • Quick Ratio: 2.71%
Misc:
  • Average Volume: 1.34 million shs.
  • Beta: 0.64
  • Short Ratio: 1.85
 
Frequently Asked Questions for Edwards Lifesciences Corporation (NYSE:EW)

What is Edwards Lifesciences Corporation's stock symbol?

Edwards Lifesciences Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."

When did Edwards Lifesciences Corporation's stock split? How did Edwards Lifesciences Corporation's stock split work?

Shares of Edwards Lifesciences Corporation split before market open on Monday, December 14th 2015. The 2-1 split was announced on Thursday, November 19th 2015. The newly created shares were payable to shareholders after the closing bell on Friday, December 11th 2015. An investor that had 100 shares of Edwards Lifesciences Corporation stock prior to the split would have 200 shares after the split.

How were Edwards Lifesciences Corporation's earnings last quarter?

Edwards Lifesciences Corporation (NYSE:EW) announced its quarterly earnings results on Tuesday, April, 25th. The company reported $0.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.12. The business earned $883.50 million during the quarter, compared to analyst estimates of $776.51 million. Edwards Lifesciences Corporation had a net margin of 20.85% and a return on equity of 25.80%. The company's quarterly revenue was up 26.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.71 earnings per share. View Edwards Lifesciences Corporation's Earnings History.

When will Edwards Lifesciences Corporation make its next earnings announcement?

Edwards Lifesciences Corporation is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for Edwards Lifesciences Corporation.

What guidance has Edwards Lifesciences Corporation issued on next quarter's earnings?

Edwards Lifesciences Corporation issued an update on its FY17 earnings guidance on Tuesday, April, 25th. The company provided earnings per share (EPS) guidance of $3.43-3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.41. The company issued revenue guidance of $3.2-3.4 billion, compared to the consensus revenue estimate of $3.26 billion.Edwards Lifesciences Corporation also updated its Q2 guidance to $0.82-0.92 EPS.

Where is Edwards Lifesciences Corporation's stock going? Where will Edwards Lifesciences Corporation's stock price be in 2017?

22 brokerages have issued twelve-month price objectives for Edwards Lifesciences Corporation's shares. Their forecasts range from $14.00 to $150.00. On average, they anticipate Edwards Lifesciences Corporation's share price to reach $114.95 in the next year. View Analyst Ratings for Edwards Lifesciences Corporation.

What are analysts saying about Edwards Lifesciences Corporation stock?

Here are some recent quotes from research analysts about Edwards Lifesciences Corporation stock:

  • 1. According to Zacks Investment Research, "Over the last three months, Edwards Lifesciences has outperformed the Zacks categorized Medical - Instruments industry. We believe several recent FDA approvals received by the company including its SAPIEN 3 THV for valve-in-valve procedures and INSPIRIS RESILIA aortic valve have been boosting the investors’ confidence over the stock. Also, Edwards Lifesciences’ long-term growth strategy buoys optimism. The company’s focus on bulding its pipeline to strengthen its foothold across all its operating businesses is also encouraging. However, higher operating expenses continue to be a woe. The stock’s valuation also remains stretched on huge investments in the launch and promotion of products. Stiff competition, currency headwind and reimbursement issues are other challenges." (7/18/2017)
  • 2. Cowen and Company analysts commented, "After hosting meetings with management last week, attending ACC, and reviewing early 1Q'17 MedMine hospital purchasing data, we remain bullish on Edwards' long term growth prospects. We are optimistic that additional layers of growth will be provided by low risk, asymptomatic and moderate AS indications along with EW's mitral and tricuspid platforms. Reiterate Outperform." (3/28/2017)

Who are some of Edwards Lifesciences Corporation's key competitors?

Who are Edwards Lifesciences Corporation's key executives?

Edwards Lifesciences Corporation's management team includes the folowing people:

  • Michael A. Mussallem, Chairman of the Board, Chief Executive Officer
  • Scott B. Ullem, Chief Financial Officer, Corporate Vice President
  • Donald E. Bobo Jr., Corporate Vice President - Heart Valve Therapy
  • Catherine M. Szyman, Corporate Vice President- Critical Care
  • Patrick Bruno Verguet, Corporate Vice President- Europe, Middle East and Africa
  • Huimin Wang M.D., Corporate Vice President- Japan, Asia and Pacific
  • Larry L. Wood, Corporate Vice President - Transcatheter Heart Valve Therapy
  • Bernard J. Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
  • Kieran T. Gallahue, Independent Director
  • Leslie Stone Heisz, Independent Director

Who owns Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include US Bancorp DE (0.11%), Rockefeller Financial Services Inc. (0.11%), National Pension Service (0.10%), Chevy Chase Trust Holdings Inc. (0.09%), Bank of Montreal Can (0.08%) and Factory Mutual Insurance Co. (0.06%). Company insiders that own Edwards Lifesciences Corporation stock include Barbara J Mcneil, Bernard J Zovighian, Catherine M Szyman, Donald E Bobo Jr, Donald E Bobo, Jr, Dylan Sidoo, Huimin Wang, John T Cardis, Kieran Gallahue, Larry L Wood, Michael A Mussallem, Nick Demare, Patrick B Verguet, Robert WA Sellers, Schack Wesley W Von, Steven R Loranger and West Petroleum Corp East. View Institutional Ownership Trends for Edwards Lifesciences Corporation.

Who sold Edwards Lifesciences Corporation stock? Who is selling Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Bank of Montreal Can, First National Bank of Omaha, Fox Run Management L.L.C., Cohen Lawrence B, OLD National Bancorp IN, Exxonmobil Investment Management Inc. TX and Bremer Trust National Association. Company insiders that have sold Edwards Lifesciences Corporation stock in the last year include Bernard J Zovighian, Donald E Bobo, Jr, Huimin Wang, John T Cardis, Larry L Wood, Michael A Mussallem, Patrick B Verguet, Robert WA Sellers and Schack Wesley W Von. View Insider Buying and Selling for Edwards Lifesciences Corporation.

Who bought Edwards Lifesciences Corporation stock? Who is buying Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock was bought by a variety of institutional investors in the last quarter, including Factory Mutual Insurance Co., National Pension Service, Mn Services Vermogensbeheer B.V., US Bancorp DE, Nisa Investment Advisors LLC, Aperio Group LLC, Rockefeller Financial Services Inc. and Chesley Taft & Associates LLC. Company insiders that have bought Edwards Lifesciences Corporation stock in the last two years include Catherine M Szyman, Dylan Sidoo, Kieran Gallahue, Nick Demare, Steven R Loranger and West Petroleum Corp East. View Insider Buying and Selling for Edwards Lifesciences Corporation.

How do I buy Edwards Lifesciences Corporation stock?

Shares of Edwards Lifesciences Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Edwards Lifesciences Corporation's stock price today?

One share of Edwards Lifesciences Corporation stock can currently be purchased for approximately $118.01.


MarketBeat Community Rating for Edwards Lifesciences Corporation (NYSE EW)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  757 (Vote Outperform)
Underperform Votes:  509 (Vote Underperform)
Total Votes:  1,266
MarketBeat's community ratings are surveys of what our community members think about Edwards Lifesciences Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Edwards Lifesciences Corporation (NYSE:EW) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 15 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $114.95 (2.59% downside)

Analysts' Ratings History for Edwards Lifesciences Corporation (NYSE:EW)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017SunTrust Banks, Inc.Boost Price TargetBuy$14.00LowView Rating Details
6/30/2017Jefferies Group LLCReiterated RatingBuy$115.00LowView Rating Details
6/28/2017Canaccord GenuityReiterated RatingBuy$150.00LowView Rating Details
5/30/2017Royal Bank Of CanadaReiterated RatingBuyLowView Rating Details
5/30/2017Bank of America CorporationBoost Price TargetBuy$120.00 -> $140.00LowView Rating Details
5/16/2017Goldman Sachs Group, Inc. (The)Initiated CoverageConviction-Buy$138.00LowView Rating Details
4/26/2017Stifel NicolausBoost Price TargetBuy -> Buy$114.00 -> $118.00HighView Rating Details
3/28/2017Cowen and CompanyReiterated RatingOutperform$120.00MediumView Rating Details
3/27/2017Evercore ISIUpgradeIn-Line -> Outperform$98.50 -> $110.00LowView Rating Details
3/20/2017Northland SecuritiesSet Price TargetBuy$105.00LowView Rating Details
2/8/2017Credit Suisse Group AGSet Price TargetBuy$120.00N/AView Rating Details
2/5/2017Deutsche Bank AGReiterated RatingHold$100.00N/AView Rating Details
2/2/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
1/3/2017GuggenheimUpgradeNeutral -> Buy$120.00N/AView Rating Details
12/10/2016JMP SecuritiesReiterated RatingEqual Weight$130.00N/AView Rating Details
12/10/2016Barclays PLCReiterated RatingEqual Weight$100.00N/AView Rating Details
12/1/2016J P Morgan Chase & CoSet Price TargetBuy$120.00N/AView Rating Details
9/11/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
8/19/2016Morgan StanleyReiterated RatingBuy$140.00N/AView Rating Details
7/27/2016Citigroup Inc.Boost Price TargetSell$86.00 -> $94.00N/AView Rating Details
7/27/2016BMO Capital MarketsReiterated RatingBuy$120.00N/AView Rating Details
6/21/2016William BlairReiterated RatingOutperformN/AView Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$123.00N/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$101.00N/AView Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$90.00 -> $92.00N/AView Rating Details
(Data available from 7/22/2015 forward)

Earnings

Earnings History for Edwards Lifesciences Corporation (NYSE:EW)
Earnings by Quarter for Edwards Lifesciences Corporation (NYSE:EW)
Earnings History by Quarter for Edwards Lifesciences Corporation (NYSE EW)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2017$0.88N/AView Earnings Details
4/25/2017Q1 2017$0.82$0.94$776.51 million$883.50 millionViewN/AView Earnings Details
2/1/2017Q416$0.72$0.75$760.85 million$767.70 millionViewN/AView Earnings Details
10/25/2016Q316$0.68$0.68$749.14 million$739.40 millionViewN/AView Earnings Details
7/26/2016Q216$0.70$0.76$724.26 million$759.30 millionViewN/AView Earnings Details
4/26/2016Q116$0.66$0.71$664.53 million$697.30 millionViewN/AView Earnings Details
2/2/2016Q415$0.62$0.63$647.44 million$671.10 millionViewN/AView Earnings Details
10/26/2015Q315$0.98$1.07$598.29 million$615.00 millionViewN/AView Earnings Details
7/28/2015Q215$1.05$1.13$604.97 million$616.80 millionViewN/AView Earnings Details
4/23/2015Q115$1.04$1.12$585.16 million$590.30 millionViewN/AView Earnings Details
2/3/2015Q414$0.95$1.06$610.50 million$618.00 millionViewListenView Earnings Details
10/23/2014Q314$0.72$0.80$546.10 million$607.40 millionViewListenView Earnings Details
7/29/2014Q214$0.77$0.88$545.10 million$547.00 millionViewListenView Earnings Details
4/24/2014Q114$0.69$0.76$523.10 million$522.40 millionViewListenView Earnings Details
2/3/2014Q413$0.82$0.91$533.82 million$536.00 millionViewN/AView Earnings Details
10/28/2013Q313$0.66$0.68$490.96 million$496.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.76$0.82$514.59 million$517.20 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.76$0.72$518.69 million$496.70 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.77$0.77$499.46 million$510.50 millionViewN/AView Earnings Details
10/19/2012$0.56$0.58ViewN/AView Earnings Details
7/24/2012$0.66$0.67ViewN/AView Earnings Details
2/2/2012$0.59$0.62ViewN/AView Earnings Details
10/19/2011$0.39$0.38ViewN/AView Earnings Details
7/21/2011$0.50$0.49ViewN/AView Earnings Details
4/20/2011$0.42$0.51ViewN/AView Earnings Details
2/2/2011$0.53$0.55ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Edwards Lifesciences Corporation (NYSE:EW)
2017 EPS Consensus Estimate: $3.40
2018 EPS Consensus Estimate: $3.99
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.82$0.85$0.84
Q2 20174$0.87$0.89$0.88
Q3 20174$0.78$0.84$0.81
Q4 20174$0.86$0.89$0.88
Q1 20183$0.95$1.09$1.01
Q2 20183$0.98$1.04$1.00
Q3 20183$0.92$0.98$0.94
Q4 20183$1.01$1.05$1.03
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Edwards Lifesciences Corporation (NYSE:EW)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Edwards Lifesciences Corporation (NYSE:EW)
Insider Ownership Percentage: 2.13%
Institutional Ownership Percentage: 83.62%
Insider Trades by Quarter for Edwards Lifesciences Corporation (NYSE:EW)
Institutional Ownership by Quarter for Edwards Lifesciences Corporation (NYSE:EW)
Insider Trades by Quarter for Edwards Lifesciences Corporation (NYSE:EW)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/29/2017Donald E. Bobo, Jr.VPSell5,600$117.15$656,040.00View SEC Filing  
6/7/2017Michael A. MussallemCEOSell32,900$118.05$3,883,845.00View SEC Filing  
5/31/2017Patrick B. VerguetVPSell10,000$114.88$1,148,800.00View SEC Filing  
5/19/2017Dylan SidooDirectorBuy25,000$0.11$2,750.00
5/19/2017Patrick B. VerguetVPSell22,631$113.16$2,560,923.96View SEC Filing  
5/15/2017Patrick B. VerguetVPSell11,500$111.64$1,283,860.00View SEC Filing  
5/8/2017Donald E. Bobo, Jr.VPSell19,100$110.34$2,107,494.00View SEC Filing  
5/4/2017Donald E. Bobo, Jr.VPSell34,120$109.98$3,752,517.60View SEC Filing  
5/3/2017Michael A. MussallemCEOSell49,100$109.71$5,386,761.00View SEC Filing  
4/28/2017Michael A. MussallemCEOSell49,100$109.78$5,390,198.00View SEC Filing  
4/27/2017Bernard J. ZovighianVPSell18,050$109.21$1,971,240.50View SEC Filing  
4/5/2017Donald E. Bobo, Jr.VPSell13,720$93.58$1,283,917.60View SEC Filing  
3/30/2017Patrick B. VerguetVPSell24,000$93.90$2,253,600.00View SEC Filing  
3/6/2017Donald E. Bobo, Jr.VPSell13,720$90.01$1,234,937.20View SEC Filing  
2/16/2017Michael A. MussallemCEOSell49,100$89.63$4,400,833.00View SEC Filing  
2/3/2017Kieran GallahueDirectorBuy3,000$90.10$270,300.00View SEC Filing  
1/13/2017Michael A. MussallemCEOSell49,100$97.08$4,766,628.00View SEC Filing  
1/12/2017Donald E. Bobo, Jr.VPSell13,720$97.47$1,337,288.40View SEC Filing  
1/12/2017Dylan SidooDirectorBuy30,000$0.13$3,900.00
1/11/2017Dylan SidooDirectorBuy20,000$0.13$2,600.00
12/19/2016Michael A. MussallemCEOSell49,100$91.96$4,515,236.00View SEC Filing  
12/5/2016Huimin WangVPSell13,650$83.53$1,140,184.50View SEC Filing  
12/1/2016Larry L. WoodVPSell13,258$81.85$1,085,167.30View SEC Filing  
11/30/2016Catherine M. SzymanVPBuy12,870$83.43$1,073,744.10View SEC Filing  
11/29/2016Kieran GallahueDirectorBuy3,000$84.63$253,890.00View SEC Filing  
11/22/2016Michael A. MussallemCEOSell49,100$84.67$4,157,297.00View SEC Filing  
11/7/2016Huimin WangVPSell13,650$91.29$1,246,108.50View SEC Filing  
11/2/2016Donald E. Bobo, Jr.VPSell15,000$90.13$1,351,950.00View SEC Filing  
11/1/2016Larry L. WoodVPSell13,257$93.27$1,236,480.39View SEC Filing  
10/27/2016Michael A. MussallemCEOSell49,100$92.77$4,555,007.00View SEC Filing  
10/5/2016Huimin WangVPSell13,650$120.04$1,638,546.00View SEC Filing  
10/3/2016Larry L. WoodVPSell13,257$119.27$1,581,162.39View SEC Filing  
9/6/2016Huimin WangVPSell13,650$115.72$1,579,578.00View SEC Filing  
9/2/2016Donald E. Bobo, Jr.VPSell18,000$115.78$2,084,040.00View SEC Filing  
8/26/2016Patrick B. VerguetVPSell5,000$114.88$574,400.00View SEC Filing  
8/24/2016Patrick B. VerguetVPSell5,000$116.81$584,050.00View SEC Filing  
8/23/2016Patrick B. VerguetVPSell10,092$117.53$1,186,112.76View SEC Filing  
8/11/2016Michael A. MussallemCEOSell49,100$114.01$5,597,891.00View SEC Filing  
8/10/2016John T. CardisDirectorSell5,000$113.21$566,050.00View SEC Filing  
8/9/2016Patrick B. VerguetVPSell10,000$113.48$1,134,800.00View SEC Filing  
8/5/2016Huimin WangVPSell13,650$113.03$1,542,859.50View SEC Filing  
8/1/2016Larry L. WoodVPSell13,257$114.24$1,514,479.68View SEC Filing  
8/1/2016Schack Wesley W. VonDirectorSell6,000$113.98$683,880.00View SEC Filing  
7/29/2016Robert W.A. SellersVPSell10,000$114.33$1,143,300.00View SEC Filing  
7/28/2016Michael A. MussallemCEOSell49,100$113.31$5,563,521.00View SEC Filing  
7/5/2016Huimin WangVPSell13,650$98.44$1,343,706.00View SEC Filing  
7/1/2016Larry L. WoodVPSell13,257$98.79$1,309,659.03View SEC Filing  
6/8/2016Michael A MussallemCEOSell49,100$102.75$5,045,025.00View SEC Filing  
6/6/2016Huimin WangVPSell13,650$101.34$1,383,291.00View SEC Filing  
6/3/2016Larry L WoodVPSell13,257$101.38$1,343,994.66View SEC Filing  
5/31/2016Donald E Bobo JrVPSell18,000$99.04$1,782,720.00View SEC Filing  
5/24/2016Steven R LorangerDirectorBuy5,000$101.07$505,350.00View SEC Filing  
5/18/2016Patrick B VerguetVPSell13,000$102.75$1,335,750.00View SEC Filing  
5/17/2016Patrick B VerguetVPSell5,000$105.00$525,000.00View SEC Filing  
5/16/2016Patrick B VerguetVPSell3,000$104.62$313,860.00View SEC Filing  
5/5/2016Huimin WangVPSell13,650$103.36$1,410,864.00View SEC Filing  
5/5/2016Michael A MussallemCEOSell59,000$104.12$6,143,080.00View SEC Filing  
5/2/2016Patrick B VerguetVPSell7,000$106.86$748,020.00View SEC Filing  
4/29/2016Michael A MussallemCEOSell59,000$106.13$6,261,670.00View SEC Filing  
4/5/2016Huimin WangVPSell13,650$103.97$1,419,190.50View SEC Filing  
3/17/2016Michael A MussallemCEOSell59,000$84.39$4,979,010.00View SEC Filing  
3/7/2016Huimin WangVPSell13,650$87.17$1,189,870.50View SEC Filing  
2/18/2016Michael A. MussallemCEOSell59,000$86.94$5,129,460.00View SEC Filing  
2/18/2016Patrick B. VerguetVPSell5,000$87.00$435,000.00View SEC Filing  
2/16/2016Patrick B. VerguetVPSell8,000$81.58$652,640.00View SEC Filing  
2/5/2016Huimin WangVPSell13,650$83.46$1,139,229.00View SEC Filing  
2/4/2016Barbara J. McneilDirectorSell4,000$83.29$333,160.00View SEC Filing  
1/21/2016Patrick B. VerguetVPSell8,000$77.00$616,000.00View SEC Filing  
1/6/2016Nick DemareDirectorBuy15,000$0.08$1,200.00
1/5/2016Huimin WangVPSell13,650$78.50$1,071,525.00View SEC Filing  
1/5/2016Michael A. MussallemCEOSell59,000$79.82$4,709,380.00View SEC Filing  
12/17/2015Michael A. MussallemCEOSell59,000$81.85$4,829,150.00View SEC Filing  
12/15/2015Patrick B. VerguetVPSell8,000$80.87$646,960.00View SEC Filing  
12/4/2015Huimin WangVPSell6,880$157.96$1,086,764.80View SEC Filing  
11/27/2015Patrick B. VerguetVPSell7,500$164.50$1,233,750.00View SEC Filing  
11/23/2015Robert W.A. SellersVPSell19,200$157.13$3,016,896.00View SEC Filing  
11/17/2015Patrick B. VerguetVPSell4,000$154.50$618,000.00View SEC Filing  
11/5/2015Huimin WangVPSell6,920$156.01$1,079,589.20View SEC Filing  
11/3/2015Patrick B. VerguetVPSell4,338$158.48$687,486.24View SEC Filing  
10/30/2015Patrick B. VerguetVPSell22,000$155.09$3,411,980.00View SEC Filing  
10/29/2015Michael A MussallemCEOSell29,500$154.59$4,560,405.00View SEC Filing  
10/5/2015Huimin WangVPSell6,920$154.30$1,067,756.00View SEC Filing  
10/2/2015Patrick B. VerguetVPSell4,000$154.00$616,000.00View SEC Filing  
10/1/2015Larry L. WoodVPSell7,680$141.52$1,086,873.60View SEC Filing  
9/21/2015Michael A. MussallemCEOSell29,500$142.49$4,203,455.00View SEC Filing  
9/4/2015Huimin WangVPSell6,920$135.19$935,514.80View SEC Filing  
9/1/2015Larry L. WoodVPSell7,680$137.50$1,056,000.00View SEC Filing  
8/24/2015Michael A. MussallemCEOSell29,500$135.25$3,989,875.00View SEC Filing  
8/13/2015West Petroleum Corp. EastInsiderBuy25,000$0.12$2,875.00
7/6/2015Huimin WangVPSell6,920$143.95$996,134.00View SEC Filing  
7/1/2015Larry L WoodVPSell7,680$143.51$1,102,156.80View SEC Filing  
6/24/2015Michael A MussallemCEOSell29,500$143.71$4,239,445.00View SEC Filing  
6/5/2015Huimin WangVPSell6,920$131.39$909,218.80View SEC Filing  
6/1/2015Larry L WoodVPSell7,680$130.47$1,002,009.60View SEC Filing  
5/29/2015Patrick B VerguetVPSell9,662$131.18$1,267,461.16View SEC Filing  
5/21/2015Barbara J McneilDirectorSell2,000$132.59$265,180.00View SEC Filing  
5/19/2015Robert Marc BustinDirectorSell10,000$0.18$1,750.00
5/1/2015Larry L WoodVPSell7,680$127.12$976,281.60View SEC Filing  
4/30/2015Michael A MussallemCEOSell29,500$128.99$3,805,205.00View SEC Filing  
4/6/2015Huimin WangVPSell6,920$140.24$970,460.80View SEC Filing  
4/1/2015Larry L WoodVPSell7,680$142.06$1,091,020.80View SEC Filing  
3/31/2015Robert Marc BustinDirectorBuy15,000$0.15$2,250.00
3/26/2015Michael A MussallemCEOSell29,500$140.10$4,132,950.00View SEC Filing  
3/2/2015Larry L WoodVPSell7,680$132.62$1,018,521.60View SEC Filing  
2/6/2015Huimin WangVPSell6,920$134.79$932,746.80View SEC Filing  
1/5/2015Huimin WangVPSell6,920$126.60$876,072.00View SEC Filing  
1/5/2015Michael A MussallemCEOSell29,500$128.20$3,781,900.00View SEC Filing  
12/22/2014Michael A MussallemCEOSell29,500$133.01$3,923,795.00View SEC Filing  
11/24/2014Michael A MussallemCEOSell29,500$124.25$3,665,375.00View SEC Filing  
11/13/2014Robert W.A. SellersVPSell3,400$124.27$422,518.00View SEC Filing  
11/10/2014Patrick B VerguetVPSell5,000$123.70$618,500.00View SEC Filing  
11/7/2014Schack Wesley W VonDirectorSell3,655$123.00$449,565.00View SEC Filing  
11/5/2014Huimin WangVPSell5,600$120.26$673,456.00View SEC Filing  
10/28/2014Barbara J McneilDirectorSell1,000$117.94$117,940.00View SEC Filing  
10/28/2014Michael A MussallemCEOSell29,500$117.06$3,453,270.00View SEC Filing  
10/28/2014Patrick B VerguetVPSell15,000$117.33$1,759,950.00View SEC Filing  
10/28/2014West Petroleum Corp. EastInsiderBuy15,000$0.12$1,800.00
10/27/2014Patrick B VerguetVPSell10,000$117.00$1,170,000.00View SEC Filing  
10/27/2014West Petroleum Corp. EastInsiderBuy20,000$0.13$2,600.00
10/24/2014Donald E Bobo JrVPSell30,000$114.25$3,427,500.00View SEC Filing  
10/24/2014West Petroleum Corp. EastInsiderBuy35,000$0.14$4,725.00
10/23/2014West Petroleum Corp. EastInsiderBuy40,000$0.15$5,800.00
10/6/2014Huimin WangVPSell5,600$107.00$599,200.00View SEC Filing  
10/3/2014Donald E Bobo JrVPSell25,000$105.00$2,625,000.00View SEC Filing  
9/29/2014Michael A MussallemCEOSell29,500$102.71$3,029,945.00View SEC Filing  
9/10/2014Donald E Bobo JrVPSell25,000$100.00$2,500,000.00View SEC Filing  
9/5/2014Huimin WangVPSell5,600$98.29$550,424.00View SEC Filing  
8/27/2014Carlyn D SolomonVPSell85,200$97.85$8,336,820.00View SEC Filing  
8/27/2014Michael A MussallemCEOSell29,500$98.14$2,895,130.00View SEC Filing  
8/18/2014John T CardisDirectorSell6,000$97.92$587,520.00View SEC Filing  
8/18/2014Larry L WoodVPSell63,752$97.85$6,238,133.20View SEC Filing  
8/13/2014Patrick B VerguetVPSell7,800$95.50$744,900.00View SEC Filing  
8/5/2014Patrick B VerguetVPSell15,000$94.05$1,410,750.00View SEC Filing  
8/4/2014Patrick B VerguetVPSell5,000$93.00$465,000.00View SEC Filing  
8/1/2014Patrick B VerguetVPSell5,000$92.00$460,000.00View SEC Filing  
7/31/2014Michael A MussallemCEOSell29,500$91.98$2,713,410.00View SEC Filing  
7/31/2014Robert Alexander IngramDirectorSell12,500$90.26$1,128,250.00View SEC Filing  
7/31/2014Robert W.A. SellersVPSell8,850$91.47$809,509.50View SEC Filing  
7/30/2014Donald E Bobo JrVPSell23,270$92.00$2,140,840.00View SEC Filing  
7/7/2014Huimin WangVPSell5,600$87.79$491,624.00View SEC Filing  
6/27/2014Donald E Bobo JrVPSell25,000$87.00$2,175,000.00View SEC Filing  
6/24/2014Michael A MussallemCEOSell29,500$85.38$2,518,710.00View SEC Filing  
6/5/2014Huimin WangVPSell5,600$80.73$452,088.00View SEC Filing  
5/30/2014Barbara J McneilDirectorSell1,200$81.20$97,440.00View SEC Filing  
5/28/2014Michael A MussallemCEOSell29,500$79.33$2,340,235.00View SEC Filing  
4/14/2014Donald Bobo, Jr.VPSell25,000$82.00$2,050,000.00View SEC Filing  
4/10/2014Michael MussallemCEOSell29,500$74.71$2,203,945.00View SEC Filing  
4/7/2014Huimin WangVPSell5,600$74.03$414,568.00View SEC Filing  
3/24/2014Michael BowlinDirectorSell1,093$72.33$79,056.69View SEC Filing  
3/6/2014Robert W.A. SellersVPSell1,650$72.88$120,252.00View SEC Filing  
2/6/2014Michael MussallemCEOSell29,500$66.92$1,974,140.00View SEC Filing  
1/27/2014Michael BowlinDirectorSell1,092$68.65$74,965.80View SEC Filing  
1/9/2014Michael MussallemCEOSell29,500$67.04$1,977,680.00View SEC Filing  
1/6/2014Huimin WangVPSell5,600$67.14$375,984.00View SEC Filing  
12/11/2013Patrick VerguetVPSell10,000$62.34$623,400.00View SEC Filing  
12/5/2013Huimin WangVPSell4,650$64.65$300,622.50View SEC Filing  
12/4/2013Michael MussallemCEOSell29,500$64.90$1,914,550.00View SEC Filing  
10/9/2013Michael MussallemCEOSell29,500$72.63$2,142,585.00View SEC Filing  
10/4/2013Huimin WangVPSell4,850$72.19$350,121.50View SEC Filing  
9/12/2013Michael MussallemCEOSell29,500$71.82$2,118,690.00View SEC Filing  
9/5/2013Huimin WangVPSell4,850$71.24$345,514.00View SEC Filing  
8/8/2013Michael MussallemCEOSell29,500$72.28$2,132,260.00View SEC Filing  
8/5/2013Huimin WangVPSell4,850$72.30$350,655.00View SEC Filing  
8/1/2013Patrick VerguetVPSell20,000$73.15$1,463,000.00View SEC Filing  
7/10/2013Michael A MussallemCEOSell29,500$65.60$1,935,200.00View SEC Filing  
7/5/2013Huimin WangVPSell4,850$65.69$318,596.50View SEC Filing  
6/6/2013Michael A MussallemCEOSell29,500$66.25$1,954,375.00View SEC Filing  
6/5/2013Huimin WangVPSell4,850$65.11$315,783.50View SEC Filing  
5/13/2013Paul C RedmondVPSell5,000$67.35$336,750.00View SEC Filing  
5/8/2013Michael A MussallemCEOSell29,200$64.24$1,875,808.00View SEC Filing  
5/7/2013Thomas M AbateCFOSell15,000$63.75$956,250.00View SEC Filing  
5/3/2013Schack Wesley W VonDirectorBuy1,000$64.00$64,000.00View SEC Filing  
5/1/2013David E I PyottDirectorBuy3,000$62.95$188,850.00View SEC Filing  
5/1/2013John H Kehl JrVPSell12,500$62.72$784,000.00View SEC Filing  
4/26/2013Schack Wesley W VonDirectorBuy2,000$64.95$129,900.00View SEC Filing  
4/10/2013Michael A MussallemCEOSell35,000$83.37$2,917,950.00View SEC Filing  
3/13/2013John H Kehl JrVPSell12,500$87.75$1,096,875.00View SEC Filing  
10/5/2012Huimin WangVPSell6,250$109.88$686,750.00View SEC Filing  
10/4/2012Donald E Bobo JrVPSell11,530$110.14$1,269,914.20View SEC Filing  
8/9/2012Michael A MussallemCEOSell35,000$98.69$3,454,150.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Edwards Lifesciences Corporation (NYSE:EW)
Latest Headlines for Edwards Lifesciences Corporation (NYSE:EW)
Source:
DateHeadline
americanbankingnews.com logoCritical Comparison: Edwards Lifesciences Corporation (NYSE:EW) vs. Accelerate Diagnostics (AXDX)
www.americanbankingnews.com - July 22 at 12:12 AM
finance.yahoo.com logoIntuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues
finance.yahoo.com - July 21 at 3:15 PM
finance.yahoo.com logoathenahealth (ATHN) Shares Rally on Earnings Beat in Q2
finance.yahoo.com - July 21 at 3:15 PM
finance.yahoo.com logoEdwards Lifesciences: Cramer's Top Takeaways
finance.yahoo.com - July 20 at 12:15 AM
finance.yahoo.com logoEdwards Lifesciences (EW) Q2 Earnings: A Surprise in Store?
finance.yahoo.com - July 19 at 7:11 PM
finance.yahoo.com logoCramer Remix: Snap is the No. 1 reason to own Facebook
finance.yahoo.com - July 19 at 7:11 PM
americanbankingnews.com logoQ2 2018 EPS Estimates for Edwards Lifesciences Corporation Reduced by Analyst (NYSE:EW)
www.americanbankingnews.com - July 19 at 1:48 PM
americanbankingnews.com logoEdwards Lifesciences Corporation to Post Q3 2017 Earnings of $0.83 Per Share, SunTrust Banks Forecasts (EW)
www.americanbankingnews.com - July 18 at 9:54 AM
nasdaq.com logoHaemonetics Plasma Arm Advances, Blood Center Sluggish - Nasdaq
www.nasdaq.com - July 17 at 7:27 PM
finance.yahoo.com logoWhy Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock?
finance.yahoo.com - July 17 at 7:27 PM
finance.yahoo.com logoHaemonetics Plasma Arm Advances, Blood Center Sluggish
finance.yahoo.com - July 17 at 7:27 PM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - July 17 at 12:52 PM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) Price Target Raised to $14.00 at SunTrust Banks, Inc.
www.americanbankingnews.com - July 17 at 9:58 AM
americanbankingnews.com logoEdwards Lifesciences Corporation (NYSE:EW) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 17 at 8:53 AM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 14 at 8:20 PM
nasdaq.com logoAbbott Partners Bigfoot Biomedical to Expand in Diabetics - Nasdaq
www.nasdaq.com - July 14 at 5:01 PM
nasdaq.com logoDaVita Medical Group Buys Dr. Rahn Shaw Practices in Orlando - Nasdaq
www.nasdaq.com - July 14 at 5:01 PM
finance.yahoo.com logoAvantor to Acquire VWR, Consolidation Promises Global Gains
finance.yahoo.com - July 14 at 5:01 PM
americanbankingnews.com logo$836.05 Million in Sales Expected for Edwards Lifesciences Corporation (EW) This Quarter
www.americanbankingnews.com - July 13 at 1:20 PM
finance.yahoo.com logoPAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation
finance.yahoo.com - July 13 at 5:24 AM
finance.yahoo.com logoHere's Why You Should Add ResMed to Your Portfolio Now
finance.yahoo.com - July 13 at 5:24 AM
nasdaq.com logoMasimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked ... - Nasdaq
www.nasdaq.com - July 12 at 7:12 PM
finance.yahoo.com logoEdwards Lifesciences To Host Earnings Conference Call On July 26, 2017
finance.yahoo.com - July 12 at 7:12 PM
finance.yahoo.com logoNeogen Introduces Test for Listeria in Environmental Samples
finance.yahoo.com - July 12 at 12:38 AM
nasdaq.com logoBuy 5 Top Profitable Stocks for Remarkable Returns - Nasdaq
www.nasdaq.com - July 11 at 7:36 PM
americanbankingnews.com logo Analysts Anticipate Edwards Lifesciences Corporation (NYSE:EW) Will Post Earnings of $0.88 Per Share
www.americanbankingnews.com - July 11 at 9:38 AM
americanbankingnews.com logoEdwards Lifesciences Corporation (NYSE:EW) PT Lowered to $5.00
www.americanbankingnews.com - July 11 at 7:12 AM
finance.yahoo.com logoMedtronic Valve Replacement Approval: Good News, But The Stock Still Fell
finance.yahoo.com - July 10 at 6:22 PM
finance.yahoo.com logoZacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics
finance.yahoo.com - July 8 at 10:38 AM
streetinsider.com logoEdwards Lifesciences (EW) Granted FDA Approval for INSPIRIS RESILIA Aortic Valve - StreetInsider.com
www.streetinsider.com - July 7 at 5:49 AM
nasdaq.com logoEdwards Lifesciences' INSPIRIS RESILIA Valve Wins FDA Nod
www.nasdaq.com - July 6 at 7:44 PM
finance.yahoo.com logoEdwards Lifesciences' INSPIRIS RESILIA Valve Wins FDA Nod
finance.yahoo.com - July 6 at 7:44 PM
streetinsider.com logoEdwards Lifesciences (EW) Granted FDA Approval for INSPIRIS RESILIA Aortic Valve
www.streetinsider.com - July 6 at 1:47 AM
finance.yahoo.com logoEdwards' INSPIRIS RESILIA Valve Receives FDA Approval
finance.yahoo.com - July 5 at 7:09 PM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) VP Sells $656,040.00 in Stock
www.americanbankingnews.com - July 3 at 7:29 PM
americanbankingnews.com logoJefferies Group LLC Reaffirms Buy Rating for Edwards Lifesciences Corporation (EW)
www.americanbankingnews.com - June 30 at 8:02 AM
americanbankingnews.com logoCanaccord Genuity Reaffirms "Buy" Rating for Edwards Lifesciences Corporation (EW)
www.americanbankingnews.com - June 28 at 9:16 PM
finance.yahoo.com logoEdwards Lifesciences Gets ‘Buy’ Ratings from 77% of Analysts
finance.yahoo.com - June 26 at 6:07 PM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) Rating Increased to Strong-Buy at BidaskClub
www.americanbankingnews.com - June 24 at 1:12 PM
nasdaq.com logoWhy Investors Should Buy Edwards Lifesciences (EW) Right Now - Nasdaq
www.nasdaq.com - June 23 at 5:41 PM
finance.yahoo.com logoHeart Valve Maker Trying To Pump Stock Past Buy Zone
finance.yahoo.com - June 20 at 5:46 PM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 19 at 8:50 PM
americanbankingnews.com logoEdwards Lifesciences Corporation (EW) Downgraded by BidaskClub to "Buy"
www.americanbankingnews.com - June 18 at 11:26 AM
americanbankingnews.com logo Brokerages Expect Edwards Lifesciences Corporation (EW) Will Post Quarterly Sales of $835.56 Million
www.americanbankingnews.com - June 17 at 11:44 AM
streetinsider.com logoNeovasc (NVCN) Says German Court Partially Found in Favour of ... - StreetInsider.com
www.streetinsider.com - June 16 at 3:52 PM
americanbankingnews.com logo$0.88 Earnings Per Share Expected for Edwards Lifesciences Corporation (EW) This Quarter
www.americanbankingnews.com - June 15 at 8:40 AM
americanbankingnews.com logoMichael A. Mussallem Sells 32,900 Shares of Edwards Lifesciences Corp (EW) Stock
www.americanbankingnews.com - June 8 at 7:12 PM
americanbankingnews.com logoZacks Investment Research Lowers Edwards Lifesciences Corp (EW) to Hold
www.americanbankingnews.com - June 8 at 1:36 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - June 7 at 9:44 AM
nasdaq.com logoEdwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval - Nasdaq
www.nasdaq.com - June 6 at 5:30 PM

Social

Chart

Edwards Lifesciences Corporation (EW) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by MarketBeat.com Staff